Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Feb. 25, 2014, 122 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $95.53 to $95,971,341.22.
Highlighted Stocks Traded by Insiders:
Allergan (AGN) - FREE Research Report Ingram Douglas S who is President at Allergan sold 1 shares at $125.70 on Feb. 25, 2014. Following this transaction, the President owned 1,044 shares meaning that the stake was reduced by 0.07% with the 1-share transaction.
The shares most recently traded at $126.89, up $1.19, or 0.94% since the insider transaction. Historical insider transactions for Allergan go as follows:
- 4-Week # shares sold: 4,318
- 12-Week # shares sold: 4,318
- 24-Week # shares sold: 9,318
The average volume for Allergan has been 2.4 million shares per day over the past 30 days. Allergan has a market cap of $37.0 billion and is part of the health care sector and drugs industry. Shares are up 13.02% year-to-date as of the close of trading on Tuesday.
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The stock currently has a dividend yield of 0.16%. The company has a P/E ratio of 26.1. Currently there are 10 analysts that rate Allergan a buy, no analysts rate it a sell, and 8 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on AGN - FREE TheStreet Quant Ratings rates Allergan as a
buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full
Allergan Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Spansion (CODE) - FREE Research Report Kispert John H who is President and CEO at Spansion sold 344,240 shares at $16.32 on Feb. 25, 2014. Following this transaction, the President and CEO owned 96,763 shares meaning that the stake was reduced by 78.06% with the 344,240-share transaction.
The shares most recently traded at $16.23, down $0.09, or 0.58% since the insider transaction. Historical insider transactions for Spansion go as follows:
- 4-Week # shares sold: 118,661
- 12-Week # shares sold: 118,661
- 24-Week # shares sold: 136,245
The average volume for Spansion has been 807,200 shares per day over the past 30 days. Spansion has a market cap of $958.8 million and is part of the technology sector and electronics industry. Shares are up 17.28% year-to-date as of the close of trading on Tuesday.
Spansion Inc. provides Flash memory-based embedded systems solutions worldwide. It offers a portfolio of Flash memory, microcontrollers, analog products, and mixed-signal, as well as integrated system-on-chip solutions. Currently there are 5 analysts that rate Spansion a buy, no analysts rate it a sell, and 1 rates it a hold.
Exclusive Offer: Get the latest Stock Analysis on CODE - FREE TheStreet Quant Ratings rates Spansion as a
hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full
Spansion Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Cummins (CMI) - FREE Research Report Chapman Steven M who is Group Vice President at Cummins sold 4,500 shares at $145.00 on Feb. 25, 2014. Following this transaction, the Group Vice President owned 15,286 shares meaning that the stake was reduced by 22.74% with the 4,500-share transaction.
The shares most recently traded at $146.41, up $1.41, or 0.96% since the insider transaction. Historical insider transactions for Cummins go as follows:
- 4-Week # shares sold: 15,927
- 12-Week # shares sold: 20,927
- 24-Week # shares sold: 21,627
The average volume for Cummins has been 1.6 million shares per day over the past 30 days. Cummins has a market cap of $27.3 billion and is part of the industrial goods sector and industrial industry. Shares are up 3.58% year-to-date as of the close of trading on Tuesday.
Cummins Inc. designs, manufactures, distributes, and services diesel and natural gas engines, and engine-related component products. It operates in four segments: Engine, Components, Power Generation, and Distribution. The stock currently has a dividend yield of 1.71%. The company has a P/E ratio of 18.5. Currently there are 11 analysts that rate Cummins a buy, no analysts rate it a sell, and 4 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on CMI - FREE TheStreet Quant Ratings rates Cummins as a
buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full
Cummins Ratings Report from
TheStreet Quant Ratings now.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
